14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $16.55 $18.63 Wednesday, 24th Apr 2024 ACAD stock ended at $16.59. This is 0.90% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 1.72% from a day low at $16.55 to a day high of $16.84.
90 days $16.55 $27.94
52 weeks $16.55 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Feb 18, 2021 $49.86 $50.90 $49.47 $50.42 651 561
Feb 17, 2021 $49.00 $50.21 $48.12 $50.07 792 758
Feb 16, 2021 $50.50 $50.88 $48.86 $49.12 1 038 707
Feb 12, 2021 $51.01 $51.13 $49.64 $50.13 721 171
Feb 11, 2021 $51.92 $52.64 $50.61 $51.24 660 319
Feb 10, 2021 $50.45 $52.80 $50.40 $51.63 883 329
Feb 09, 2021 $51.07 $51.76 $50.03 $50.45 782 487
Feb 08, 2021 $52.24 $52.78 $51.08 $51.28 760 081
Feb 05, 2021 $50.61 $51.95 $50.10 $51.70 796 540
Feb 04, 2021 $49.63 $51.61 $49.30 $51.07 568 267
Feb 03, 2021 $49.45 $51.21 $49.22 $49.32 1 122 982
Feb 02, 2021 $46.97 $50.30 $46.93 $49.43 1 441 541
Feb 01, 2021 $48.49 $48.90 $45.65 $46.58 1 659 637
Jan 29, 2021 $49.73 $49.96 $47.26 $48.05 950 960
Jan 28, 2021 $48.23 $49.85 $47.14 $49.54 1 388 857
Jan 27, 2021 $51.33 $51.50 $48.32 $48.61 1 548 285
Jan 26, 2021 $54.17 $54.50 $51.50 $51.61 989 766
Jan 25, 2021 $53.20 $54.58 $52.70 $53.95 1 116 497
Jan 22, 2021 $51.99 $52.99 $51.43 $52.83 562 024
Jan 21, 2021 $53.65 $53.76 $51.90 $52.01 651 737
Jan 20, 2021 $53.50 $53.90 $52.56 $53.34 794 232
Jan 19, 2021 $54.49 $54.50 $53.15 $53.37 684 093
Jan 15, 2021 $54.37 $54.73 $53.13 $53.66 755 793
Jan 14, 2021 $53.42 $54.91 $53.25 $54.46 554 240
Jan 13, 2021 $53.77 $54.45 $53.13 $53.31 629 290
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT